Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 5
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4183)
- Volume 20, 2024 (77)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 4, 2008
Errorless learning and spaced retrieval techniques to relearn instrumental activities of daily living in mild Alzheimer’s disease: A case report study
Stéphanie Thivierge, Martine Simard, Léonie Jean, Éric Grandmaison
Neuropsychiatric Disease and Treatment 2008, 4:987-999
Published Date: 10 October 2008
Validity and reliability of the Structured Clinical Interview for Depersonalization–Derealization Spectrum (SCI-DER)
Marco Mula, Stefano Pini, Simona Calugi, Matteo Preve, Matteo Masini, et al
Neuropsychiatric Disease and Treatment 2008, 4:977-986
Published Date: 10 October 2008
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
Giorgio L Colombo, Mauro Caruggi, Sergio Di Matteo, Alessandro Rossi
Neuropsychiatric Disease and Treatment 2008, 4:967-976
Published Date: 10 October 2008
The efficacy of mirtazapine in agitated patients with Alzheimer’s disease: A 12-week open-label pilot study
Sibel Cakir, Isin Baral Kulaksizoglu
Neuropsychiatric Disease and Treatment 2008, 4:963-966
Published Date: 10 October 2008
Five personality dimensions in patients with irritable bowel syndrome
Alireza Farnam, Mohammad H Somi, Firouz Sarami, Sara Farhang
Neuropsychiatric Disease and Treatment 2008, 4:959-962
Published Date: 10 October 2008
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
Ibrahim Turkoz, Cynthia A Bossie, Bryan Dirks, Carla M Canuso
Neuropsychiatric Disease and Treatment 2008, 4:949-958
Published Date: 10 October 2008
Augmentation treatment in major depressive disorder: focus on aripiprazole
J Craig Nelson, Andrei Pikalov, Robert M Berman
Neuropsychiatric Disease and Treatment 2008, 4:937-948
Published Date: 10 October 2008
The role of duloxetine in the treatment of anxiety disorders
Domenico De Berardis, Nicola Serroni, Alessandro Carano, Marco Scali, Alessandro Valchera, et al
Neuropsychiatric Disease and Treatment 2008, 4:929-935
Published Date: 10 October 2008
Risperidone long-acting injection: a review of its long term safety and efficacy
Michael K Rainer
Neuropsychiatric Disease and Treatment 2008, 4:919-927
Published Date: 10 October 2008
Attention-deficit-hyperactivity disorder and reward deficiency syndrome
Kenneth Blum, Amanda Lih-Chuan Chen, Eric R Braverman, David E Comings, Thomas JH Chen, et al
Neuropsychiatric Disease and Treatment 2008, 4:893-917
Published Date: 10 October 2008
Traumatic brain injury: future assessment tools and treatment prospects
Steven R Flanagan, Joshua B Cantor, Teresa A Ashman
Neuropsychiatric Disease and Treatment 2008, 4:877-892
Published Date: 10 October 2008
Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease
Amber Watts, Eileen M Crimmins, Margaret Gatz
Neuropsychiatric Disease and Treatment 2008, 4:865-876
Published Date: 10 October 2008
Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease
Ryszard Pluta, Marzena Utamek, Poland
Neuropsychiatric Disease and Treatment 2008, 4:855-864
Published Date: 10 October 2008
Cannabinoids in the management of spasticity associated with multiple sclerosis
Anna Maria Malfitano, Maria Chiara Proto, Maurizio Bifulco
Neuropsychiatric Disease and Treatment 2008, 4:847-853
Published Date: 10 October 2008
Potential cellular and regenerative approaches for the treatment of Parkinson’s disease
Emma L Lane, Olivia J Handley, Anne E Rosser, Stephen B Dunnett
Neuropsychiatric Disease and Treatment 2008, 4:835-845
Published Date: 10 October 2008
Intrathecal corticosteroids might slow Alzheimer’s disease progression
Joseph Martin Alisky
Neuropsychiatric Disease and Treatment 2008, 4:831-833
Published Date: 10 October 2008